The majority of the funds created the by the Project Bioshield Act of 2004 were used to target only three pathogens-Ebola, HIV virus, and Salmonella-which led some to criticize why some of the funds wasn't used to develop therapeutics against other biological agents such as anthrax.

Question

Quizplus · Accepted Answer

The Project Bioshield Act of 2004 was primarily aimed at developing and procuring vaccines, drugs, and other countermeasures against a broad array of potential biological, chemical, radiological, and nuclear (CBRN) agents that could be used in a terrorist attack against the United States, not just limited to Ebola, HIV, and Salmonella. Anthrax, for example, was one of the key pathogens targeted by the act for the development of countermeasures.

The Majority of the Funds Created the by the Project